Relationship between bridging with ventricular assist device on rejection after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 3, 2005, Pages 310-315

  Pamboukian, Salpy V ^a   Costanzo, Maria Rosa ^b   Dunlap, Stephanie ^c   Rayburn, Barry ^a   Westfall, Andrew O ^a   You, Z Y ^a   Hung, Elena ^c   McLeod, Mary ^c   Heroux, Alain ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Edward Hospital   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ANGIOCARDIOGRAPHY; ANTIBODY PRODUCTION; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HEART ASSIST DEVICE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL ANALYSIS; SUDDEN DEATH;

EID: 14644399188     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.12.008     Document Type: Article

References (16)

1. Massad M., McCarthy P.M., Smedira N.G., et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? J Thorac Cardiovasc Surg. 112:1996;1275-1283
2. Jaski B.E., Kim J.C., Naftel D.C., et al. Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy. J Heart Lung Transplant. 20:2001;449-456
3. Kerman R.H., Radovancevic B., Przybylowski P., Frazier O.H., Thomas C., Kahan B.D. LVAD treated heart recipients do not have deleterious HLA antibodies. (abstract) J Heart Lung Transplant. 20:2001;211
4. Moazami N., Itescu S., Williams M.R., Argenziano M., Weinberg A., Oz M.C. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant. 17:1998;876-880
5. McKenna D.H., Eastlund T., Segall M., Noreen H., Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant. 21:2002;1218-1224
6. Rajit J., Lietz K., Schuster M., et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg. 125:2003;578-591
7. Pagani F.D., Dyke D.B., Wright S., Cody R., Aaronson K.D. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular-assist device implantation effects on subsequent allograft rejection and survival. J Heart Lung Transplant. 20:2001;646-653
8. Lavee J., Kormos R.L., Duquesnoy R.J., et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant. 10:1991;921-930
9. Loh E., Bergin J.D., Couper G.S., Mudge G.H. Role of panel reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant. 13:1994;194-201
10. Massad M.G., Cook D.J., Schmitt S.K., et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg. 64:1997;1120-1125
11. Stringham J.C., Bull D.A., Fuller T.C., et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant. 18:1999;160-165
12. Itescu S., Andersmit J., Kocker A.A., Schuster M.D. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dise. 43:2000;67-80
13. Taylor D.O., Edwards L.B., Mohacsi P.J., et al. The registry of the International Society of Heart and Lung Transplantation twentieth official adult heart transplant report - 2003. J Heart Lung Transplant. 22:2003;616-624
14. De Nofrio D., Rho R., Morales F.J., et al. Detection of anit-HLA antibodies by flow cytometry inpatients with a left ventricular assist device is associated with early rejection following heart transplantation. Transplantation. 69:2000;814-818
15. Kirklin J.K., Naftel D.C., Bourge R.C., et al. Rejection after cardiac transplantation a time related risk factor analysis. Circulation. 86:(Suppl 2):1992;II-236-II-241
16. Baldwin W.M. III, Samaniego-Picota M., Kasper E.K., et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation. 68:1999;894-900